StockWatch
·

SANGAM (INDIA) LTD. Q2 FY27 Results

SANGAMINDQ2 FY27 Results
Filing
Result:Very Good· Market: Down#Margin expansion#Record quarter#Broad based

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue1.0K21.5%33.0%
Total Income1.1K21.1%33.9%
Expenditure980.8521.0%30.9%
PBT68.1923.6%100.1%
Net Profit53.4030.2%130.9%
OPM11.44%0.61pp1.86pp
NPM5.08%0.35pp2.13pp
EPS10.6330.3%131.1%
View full financials

Revenue +33% YoY with operating PBT (ex-exceptional) nearly doubling and margins expanding to a 6-quarter high, though a lower tax rate (21.7% vs 32.1%) flatters the 131% PAT headline versus a ~100% tax-adjusted operating gain.

SANGAM (INDIA) · Q2 FY-27 · THE VERDICT

Record High, Working Capital Strain

Sangam delivered its best-ever quarter with ₹1,045 Cr revenue (+33% YoY) and ₹53.4 Cr PAT (+131% YoY). Yet debtor days rose to 77 from 67, and guidance was reaffirmed, not raised. The market's own gauge—up 52% from the low but off its highs—captures the ambiguity.

11 Nov 2026 · 6 min read
Revenue Q2

₹1,045 Cr

+33% YoY | best-ever

PAT Q2

₹53.4 Cr

+131% YoY | highest-ever

H1 PAT run-rate

₹94 Cr

113% of FY26 full-year ₹83 Cr

Debtor Days

77 days

+10 from March ₹67 | drag

Sangam delivered its best quarter in company history: ₹1,045 Cr revenue, ₹53.4 Cr PAT, both records. The growth is real—33% YoY, 131% YoY bottom-line. But management's own disclosure reveals the cost: debtor days rose to 77 from 67 in March, driven by government tenders (₹200 Cr in H1, long-cycle ~70–90 days) and export delays. Operating cash flow remains negative, and FY27 PAT-doubling guidance was reaffirmed, not raised—a signal that execution risk is rising even as the headline looks strong.

The working capital miss

On prior calls, management signaled confidence in working capital management. Q2 broke that narrative. Debtor days climbed 10 days in six months, driven by two structural drags: (1) Government tenders, which have become ~10% of revenue (~₹200 Cr in H1 alone), carry 70–90 day payment cycles and require L1 tender credentials and technical qualification; (2) Export delays, where shipments to overseas customers now take longer than historical norms. Management promises normalization back to 45–60 days by Q4, but this is unproven. Operating cash flow is expected positive by March—contingent on both drains reversing on schedule.

Our debtor days have gone up in the current quarter from 67 days in March to 77 days in September, and there are mainly 2 reasons for it. First, we are growing our business and with government tenders. Second, export shipments are taking longer.

What changed on this call

Three material shifts from prior guidance:

  • Debtor days rose, not fell. Prior comfort on working capital normalization was not met. Government business and export delays are now explicitly flagged as structural, not temporary.

  • Leverage elevated to 1.15x D/E. Capex ₹1,500 Cr over 2–2.5 years, 70–75% debt-financed, pushed net debt/equity up from 1.0x. Management targets return to 1.0–1.1x long-term; promoter equity infusion of ₹100 Cr (₹25 Cr received) is underway to ease the climb.

  • Guidance reaffirmed, hedged language persists. FY27 PAT-doubling target (~₹166 Cr from FY26 ₹83 Cr) remains, but phrased as 'aspire' and 'relatively confident,' not committed. Despite 131% YoY delivery in Q2, tone is cautious.

Verified claims vs. the numbers

Management's on-call claims graded against delivered results

Q2 best quarter in history: revenue ₹1,045 Cr, PAT ₹53.4 Cr, EBITDA ₹127 Cr, all highest-ever

Revenue ₹1,045.3 Cr delivered; PAT ₹53.4 Cr; EBITDA ₹127 Cr. YoY growth 33% / 131% respectively. Numbers match exactly.

Fully supported

FY27 PAT doubling on track (~₹166 Cr from FY26 ₹83 Cr)

H1 PAT ₹94 Cr. Requires H2 ₹72 Cr to hit ₹166 Cr target (vs. H1 ₹94 Cr). Pace is achievable but requires sustained momentum in a typically slower half.

Supported, with caveat

Renewable energy to yield ₹50–55 Cr EBITDA annually once fully commissioned

Current ~35% of energy from captive power (up from ~10% YoY); target 50% by FY27-end. Benefit partially accrued; exact split opaque. Still pending full realization in FY28.

Overstated (timing)

Debtor days will normalize after export delays and govt. tenders ease

Debtor days rose 67→77 days in Q2, contrary to prior comfort. Normalization promised by Q4; unverified.

Contradicted

Denim utilization 96–97%; realization ₹170–175/meter

Numbers cited in call; no independent verification in result filing. Claim stands as stated.

Stated, not contradicted

Garment business nascent; will ramp to 50–60% utilization in H2

Q2 utilization 37% (only ~2% of revenue). Seasonal business; unproven ramp. Management acknowledged learning curve.

Partial; dependent on H2 delivery

Bull and bear, side by side

The ledger
  • Best-ever quarter: revenue ₹1,045 Cr, PAT ₹53.4 Cr, margins expanding (OPM 11.4%)

  • FY27 PAT doubling on track: H1 ₹94 Cr = 113% of FY26 full-year ₹83 Cr

  • Long-term capex story validated: ₹1,500 Cr over 2.5 years, ₹80–85 Cr incremental EBITDA, renewable energy ₹50–55 Cr

  • Denim at peak capacity (96–97%); yarn expansion underway; ROC improved to 13% from 7% (2 years ago)

  • Working capital deteriorated: debtor days 77 vs. prior comfort 67; government orders and export delays blamed

  • Leverage elevated to 1.15x D/E; capex ₹1,500 Cr will stretch further; path back to 1.0–1.1x dependent on EBITDA and repayment

  • Garment business nascent (37% utilization, ~2% of revenue); ramp-up unproven; seasonal demand and learning curve

  • Renewable energy benefit ₹50–55 Cr still pending; partially accrued, exact split opaque; full realization FY28

  • Guidance reaffirmed, not raised, despite 131% YoY delivery; tone 'aspire' and 'relatively confident,' not firm

Risks ranked by severity to a holder

What keeps a holder awake, in order

Working capital cycle unresolved

Medium

Debtor days at 77 (up from 67) choke operating cash flow despite EBITDA growth. Operating cash flow is negative YTD; promised positive by March (H2 execution risk). If government orders stay long-cycle and exports remain delayed, the ₹1,500 Cr capex will be funded by debt, not cash conversion.

Leverage rising during capex phase

Medium

D/E now 1.15x; capex ₹1,500 Cr (70–75% debt-financed) will push net debt to ~₹1,500 Cr before repayment cycle. If EBITDA growth stalls or interest costs rise, debt service becomes onerous. Path back to 1.0–1.1x target depends on consistent EBITDA growth and FCF generation.

Garment capacity ramp-up unproven

Medium

Garment is new to Sangam (~2% of revenue, 37% utilization Q2). Seasonal demand, learning curve. Company expects ramp to 50–60% in H2 (unverified). If garment fails to scale, the ₹80–85 Cr incremental EBITDA capex promise will underdeliver.

Renewable energy benefit timing opaque

Low-Medium

₹50–55 Cr EBITDA claimed annually; some already accrued, some pending FY28. Seasonality causes quarterly variation. If commissioning delays or output underperforms, margin expansion targets will miss.

Government orders as revenue driver carry long-cycle cash drag

Low-Medium

₹200 Cr in H1 (10% of revenue) with 70–90 day payment cycles. If government business grows and cash conversion stays poor, working capital stress will worsen despite revenue growth.

Denim capacity already at peak; growth capacity-constrained

Low

Denim utilization 96–97%; no room for top-line expansion without new capacity. Yarn expansion is underway, but garment ramp-up is the growth engine—and it's nascent.

How the market is reading it

Stock price ₹625 as of November 9, 2026. The tape tells a cautious bullish story: up 52.4% from the 52-week low (₹410), above all key moving averages (SMA20 ₹601, SMA50 ₹598, SMA200 ₹534), but down 7% from its all-time high of ₹672.5. RSI 57.9 is neutral—no overbought signal. Volume is increasing, suggesting institutional interest is building, but not at a fever pitch.

Ownership is stable and thin: FII 2.50%, DII 0.09%, Promoter 70.52% (latest FY27 Q1 filing). FII ownership ticked up 0.1pp QoQ; DII flat. This suggests foreign institutions are adding cautiously, not aggressively. Promoters remain dominant at 70.5%+, with no reported insider selling near the highs—a neutral signal (no early exit).

The price action squares with the fundamental read: the market is giving credit for record growth and long-term capex, but pricing in execution risk on working capital and garment ramp-up. The 7% fade from ATH is not a sell-off—it's profit-taking by those who bought the momentum—but it flags that sentiment has cooled from euphoria to cautious optimism.

The debate

The honest read: Sangam has real growth and a credible long-term capex plan, but execution risk is rising. Working capital deterioration is not temporary—it's structural (government orders, exports). Until management proves that debtor days can normalize and operating cash flow swing positive, the story remains growth without cash generation. FY27 PAT doubling is on track, but it's an accounting milestone, not a cash milestone. The market's own verdict (up 52% but down 7% from ATH, FII adding cautiously, no insider selling) is the right read: acknowledge the growth, monitor the cash flow, remain skeptical of the long-term capex ROI until working capital stabilizes.

What to watch next

Three concrete gates for Q3 FY27 and beyond
  • 1 · Debtor days normalization

    Management promised 45–60 day range by Q4. If debtor days decline to 65–70 by Q3, it signals government orders are converting to cash and exports are normalizing. If they stay at 75+, the working capital story is broken, and ₹1,500 Cr capex becomes a liability, not an asset.

  • 2 · Operating cash flow swing

    Promised positive by March (Q4 FY27-end). Current status is negative YTD. If Q3 shows progress towards breakeven and Q4 ends positive, the capex story regains credibility. Negative cash flow through FY27 would be a warning that leverage is structural, not temporary.

  • 3 · Garment utilization ramp

    Target 50–60% in H2 FY27 (vs. 37% in Q2). If Q3 shows ramp to 45–50%, the new segment is viable. If Q3 stays at 37–40%, garment is a distraction, not a growth engine, and the ₹80–85 Cr incremental EBITDA capex forecast becomes suspect.

The single number to track

Operating cash flow. Management's capex story depends on it. Q2 revenue ₹1,045 Cr is impressive, but if it's all locked in 77-day receivables, it's not cash. Watch H2 FY27 for the promised cash conversion. If it doesn't materialize by Q4, the long-term story unravels.

Sangam delivered its best quarter in company history and reaffirmed a credible long-term capex plan. But growth without cash is a problem, not a prize. The working capital deterioration is real, the leverage is rising, and execution risk is medium. The market's own positioning—bullish but cautious, up 52% but down 7% from ATH, FII adding but not aggressively—is the right read. Hold for the long-term story, but monitor working capital closely. If debtor days normalize and cash flow swings positive by Q4, this becomes a genuine multi-year compounder. If they don't, the ₹1,500 Cr capex will drag the stock lower. The number to track from here is operating cash flow, not PAT.

Informational and educational content only. Not investment advice.